Form 4: Regeneron Pharmaceuticals Executive Reports Stock Transactio
Insider Transaction (Form 4)
Joseph J Larosa, EVP General Counsel and Secret of Regeneron Pharmaceuticals, Inc., reported multiple transactions in common stock on August 19, 2026.
Summary
- Option exercise/conversion: acquired 12,282 Common Stock at $381.92 ($4,690,741) on August 19, 2026; holds 45,392 after (Direct).
- Tax/exercise-price withholding: disposed of 9,019 Common Stock at $830.15 ($7,487,123) on August 19, 2026; holds 36,373 after (Direct).
- Option exercise/conversion: disposed of 12,282 Non-Qualified Stock Option (right to buy) on August 19, 2026; holds 12,283 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Joseph J Larosa — Officer (EVP General Counsel and Secret)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-19 | Option exercise/conversion | Common Stock | 12,282 | $382 | $4.7M | 45,392 |
| 2026-08-19 | Tax/exercise-price withholding | Common Stock | 9,019 | $830 | $7.5M | 36,373 |
| 2026-08-19 | Option exercise/conversion | Non-Qualified Stock Option (right to buy) | 12,282 | — | — | 12,283 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-19 | Option exercise/conversion (12,282 shares) |
| 2026-08-19 | Tax/exercise-price withholding (9,019 shares) |
| 2026-08-19 | Option exercise/conversion (12,282 shares) |
Keywords
insider transaction, Form 4, REGN, REGENERON PHARMACEUTICALS, INC., neutral, Joseph J Larosa
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.